Biostage Successfully Regenerates Esophagus in Groundbreaking Pre-Clinical Work with Mayo Clinic; Data Provides ‘Proof of Concept’ to Seek FDA Approval for Clinical Trials

Biostage, Inc. (BSTG), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea today announced significant, pre-clinical data, including the complete regeneration of a segment of the esophagus, from its…

The post Biostage Successfully Regenerates Esophagus in Groundbreaking Pre-Clinical Work with Mayo Clinic; Data Provides ‘Proof of Concept’ to Seek FDA Approval for Clinical Trials appeared first on Oral Health Group.

from Cosmetic Dentist http://ift.tt/1s7rG8k via hop over to this website
from Tumblr http://ift.tt/1TcHvS7